MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

07 Jul 2025 Evaluate
Revenue reduced marginally to stand at Rs. 4306.95 millions during the quarter ended March 2025. The figure stood at Rs. 4413.75 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -1300.89 millions as compared to Net Profit of Rs. 6.00 millions of corresponding quarter ended March 2024Operating profit Margin for the quarter ended March 2025 slipped to -1542.26% as compared to 499.80% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 4306.95 4413.75 -2.42 16730.75 16856.32 -0.74 16730.75 16856.32 -0.74
Other Income 0.78 14.68 -94.69 18.91 130.30 -85.49 18.91 130.30 -85.49
PBIDT -1542.26 499.80 -408.58 -245.67 1661.35 -114.79 -245.67 1661.35 -114.79
Interest 176.72 241.60 -26.85 745.78 871.42 -14.42 745.78 871.42 -14.42
PBDT -1718.98 258.20 -765.76 -991.45 789.93 -225.51 -991.45 789.93 -225.51
Depreciation 157.67 147.00 7.26 623.89 607.18 2.75 623.89 607.18 2.75
PBT -1876.65 111.20 -1787.63 -1615.34 182.75 -983.91 -1615.34 182.75 -983.91
TAX -575.76 105.20 -647.30 -478.53 132.74 -460.50 -478.53 132.74 -460.50
Deferred Tax -575.76 105.20 -647.30 -478.53 132.74 -460.50 -478.53 132.74 -460.50
PAT -1300.89 6.00 -21781.50 -1136.81 50.01 -2373.17 -1136.81 50.01 -2373.17
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) -31.40 9.74 -422.47 -1.29 8.62 -114.91 -1.29 8.62 -114.91
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..